Elemir Macedo de Souza

Elemir Macedo de Souza

Auto-generated profile, based on publicly available information

Elemir Macedo de Souza

Universidade Estadual de Campinas (UNICAMP), Faculdade de Ciências Médicas, Departamento de Medicina, Divisão de Dermatologia, Campinas, SP, Brazil

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2023 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
BLBarbara Hartung Lovato
Barbara Hartung Lovato
LFLeticia Fogagnolo
Leticia Fogagnolo
ESElemir Macedo de Souza
Elemir Macedo de Souza
LSLarissa Juliana Batista da Silva
Larissa Juliana Batista da Silva
PVPaulo Velho
Paulo Velho
FTFernanda Teixeira
Fernanda Teixeira
Background: Only a fraction of patients with cutaneous lupus erythematosus (CLE) will eventually progress toward systemic disease (SLE). Objective: To find inflammatory biomarkers which could predict the progression of cutaneous lupus erythematosus (CLE) into systemic lupus erythematosus (SLE) using immunohistochemical (IHC) assays. Methods: Immunohistochemical markers for cytotoxic, inflammatory, and anti-inflammatory responses and morphometric methods were applied to routine paraffin sections of skin biopsies, taken from lesions of 59 patients with discoid lupus, subacute lupus, and lupus tumidus. For the diagnosis of SLE, patients were classified by both the American College of Rheumatology (ACR-82) and the Systemic Lupus International Collaborating Clinics (SLICC-12) systems. Results: Skin samples from CLE/SLE + patients presented higher expression of IL-1β (ARC-82: p = 0.024; SLICC-12: p = 0.0143) and a significantly higher number of cells marked with granzyme B and perforin (ARC: p = 0.0097; SLICC-12: p = 0.0148). Biopsies from CLE/SLE- individuals had higher expression of IL-17 (ARC-82: p = 0.0003; SLICC-12: p = 0.0351) and presented a positive correlation between the density of granzyme A + and FoxP3+ cells (ARC-82: p = 0.0257; SLICC-12: p = 0.0285) and CD8+ cells (ARC-82: p = 0.0075; SLICC-12: p = 0.0102), as well as between granulysin-positive and CD8+ cells (ARC-82: p = 0.0024; SLICC-12: p = 0.0116). Study limitations: Patients were evaluated at a specific point in their evolution and according to the presence or not of systemic disease. The authors cannot predict how many more, from each group, would have evolved towards SLE in the following years. Conclusions: In this cohort, immunohistochemical findings suggested that patients with a tendency to systemic disease will show strong reactivity for IL-1β, while those with purely cutaneous involvement will tend to express IL-17 more intensely.

1 January 2020 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
OLOriete Gerin Leite
Oriete Gerin Leite
STSandra Tagliolatto
Sandra Tagliolatto
ESElemir Macedo de Souza
Elemir Macedo de Souza
MCMaria Letícia Cintra
Maria Letícia Cintra
Topical use of immune response modifiers, such as imiquimod, has increased in dermatology. Although its topical use is well tolerated, it may be associated with exacerbations of generalized cutaneous inflammatory diseases, possibly through the systemic circulation of pro-inflammatory cytokines. This report describes a case of development of pityriasis rubra pilaris, a rare erythematous-papulosquamous dermatosis, in a woman aged 60 years during treatment with imiquimod 5% cream for actinic keratosis. It evolved with erythrodermic conditions and palmoplantar keratoderma, presenting progressive clinical resolution after the introduction of methotrexate. The authors emphasize the importance of recognizing possible systemic reactions associated with the topical use of imiquimod.

1 October 2022 in Sao Paulo Medical Journal
Verified
Journal Article
Open access
ASAndressa Christine Ferreira Silva
Andressa Christine Ferreira Silva
LKLaura Moya Kazmarek
Laura Moya Kazmarek
ESElemir Macedo de Souza
Elemir Macedo de Souza
MCMaria Letícia Cintra
Maria Letícia Cintra
FTFernanda Teixeira
Fernanda Teixeira
The number of bariatric surgeries performed worldwide is growing. Among the main short, medium or long-term complications after surgery are nutritional deficiencies. Many of these, such as those of Zn, Cu and vitamins A, B1, B3, B6 and B12, are manifested by dermatological lesions before potentially fatal systemic disorders occur. To identify the main dermatological manifestations associated with nutritional deficiencies after bariatric surgery, and the associated variables. Integrative literature review carried out at a public university in Brazil. This was a case report and a review of health research portals and databases of national and international biomedical journals, without publication date limitation. The descriptors used for searches followed the ideal methodology for each database/search portal: “bariatric surgery”, “skin”, “skin disease”, “skin manifestation”, “deficiency disease” and “malnutrition”. A total of 59 articles were selected, among which 23 were review articles or articles that addressed specific dermatological manifestations. The other 36 articles described 41 cases, which were organized into a table with the clinical variables. Although nutritional deficiencies are expected as complications after bariatric surgery, few articles relating them to their dermatological manifestations were found. It is important to recognize skin changes caused by nutritional deficiencies in patients treated via bariatric surgery, as these may occur before systemic complications appear and are easier to diagnose when the patient does not have any systemic symptoms yet. However, there is generally a delay between the appearance of skin lesions and making the diagnosis of nutritional deficiency.

1 April 2007 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
KMKonradin Metze
Konradin Metze
VBValcinir Bedin
Valcinir Bedin
RARandall Luis Adam
Randall Luis Adam
ESElemir Macedo de Souza
Elemir Macedo de Souza
MCMaria Letícia Cintra
Maria Letícia Cintra

25 March 2023 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
MDMarina Rovani Drummond
Marina Rovani Drummond
LSLuciene Silva dos Santos
Luciene Silva dos Santos
LSLais Bomediano Souza
Lais Bomediano Souza
GMGabriela Nero Mitsuushi
Gabriela Nero Mitsuushi
MCMaria Letícia Cintra
Maria Letícia Cintra
PVPaulo Velho
Paulo Velho
Livedoid vasculopathy (LV) manifests as ulcers and atrophic white scars on the lower extremities. The main known etiopathogenesis is hypercoagulability with thrombus formation, followed by inflammation. Thrombophilia, collagen and myeloproliferative diseases may induce LV, but the idiopathic (primary) form predominates. Bartonella spp. may cause intra-endothelial infection and skin manifestations caused by these bacteria may be diverse, including leukocytoclastic vasculitis and ulcers. The aim of this study was to investigate the presence of bacteremia by Bartonella spp. in patients with difficult-to-control chronic ulcers diagnosed as primary LV. Questionnaires and molecular tests (conventional PCR, nested PCR and real-time PCR) were applied and liquid and solid cultures were performed in the blood samples and blood clot of 16 LV patients and 32 healthy volunteers. Bartonella henselae DNA was detected in 25% of LV patients and in 12.5% of control subjects but failed to reach statistically significant differences (p = 0.413). Due to the rarity of primary LV, the number of patients studied was small and there was greater exposure of the control group to risk factors for Bartonella spp. Although there was no statistically significant difference between the groups, the DNA of B. henselae was detected in one of every four patients, which reinforces the need to investigate Bartonella spp. in patients with primary LV.

21 September 2022 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
LLLuciana Prates Nogueira de Lima
Luciana Prates Nogueira de Lima
CACarolina Viza Amorim
Carolina Viza Amorim
RMRachel Martins Marinho
Rachel Martins Marinho
MCMaria Letícia Cintra
Maria Letícia Cintra
ESElemir Macedo de Souza
Elemir Macedo de Souza
Congenital and self-healing Hashimoto-Pritzker reticulohistiocytosis is the benign variant of the Langerhans cell histiocytosis (LCH) group. It is characterized by multiple skin lesions (congenital or appearing during the first days after birth), without systemic manifestations and spontaneous resolution in days to months. The authors report the case of a boy with a single congenital leg skin lesion, a rare disease variant. Through histopathology, a dense skin infiltration of S100 protein-, CD1a-, CD207-immunomarked cells was found. KI67 index was high (62%). A complete spontaneous resolution occurred 07 days after the biopsy (25 days after birth). Monolesional disease, distal limb lesion, absence of lesions in the mucous membrane or seborrheic area, and less than 25 percent of LCs with Birbeck granules were said to be possible clues for a favorable prognosis in LCs histiocytosis. But, as a precautionary measure, the child will be followed up until at least 2 years of age.